Abstract
The main non-surgical treatments for liver lesions include chemotherapy, targeted treatments, chemoembolization and radiofrequency ablation. The post-treatment imaging features are variable and depend on the initial appearance of the lesion, the type of treatment and the imaging modality. Evaluation of tumour response to treatment is important. RECIST criteria based on unidimensional lesion measurements may not always be appropriate. Other evaluation criteria (Choi for GIST, EASL for HCC or Chun criteria.) may be more relevant.
Copyright © 2011. Published by Elsevier Masson SAS.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carcinoma, Hepatocellular / diagnosis
-
Carcinoma, Hepatocellular / mortality
-
Carcinoma, Hepatocellular / therapy*
-
Catheter Ablation / methods*
-
Chemoembolization, Therapeutic / methods*
-
Colorectal Neoplasms / diagnosis
-
Colorectal Neoplasms / mortality
-
Colorectal Neoplasms / therapy
-
Diagnostic Imaging / methods
-
Disease Progression
-
Gastrointestinal Stromal Tumors / metabolism
-
Gastrointestinal Stromal Tumors / mortality
-
Gastrointestinal Stromal Tumors / therapy
-
Humans
-
Image Processing, Computer-Assisted
-
Liver / pathology
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / mortality
-
Liver Neoplasms / secondary
-
Liver Neoplasms / therapy*
-
Magnetic Resonance Imaging
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / mortality
-
Neoplasm Recurrence, Local / therapy
-
Radiology, Interventional / methods*
-
Treatment Outcome